Clinical Trials Logo

Lung Cancer Metastatic clinical trials

View clinical trials related to Lung Cancer Metastatic.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04069936 Terminated - Lung Cancer Clinical Trials

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Start date: October 15, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of MILs™ - NSCLC alone and in combination with nivolumab with or without tadalafil in subjects with locally advanced and unresectable or metastatic NSCLC who are refractory or relapsing to a PD-1 containing regimen.

NCT ID: NCT03400748 Terminated - Lung Cancer Clinical Trials

ANET Electrosurgery Applicator Pilot Evaluation Study

Start date: April 23, 2018
Phase: N/A
Study type: Interventional

Evaluate the preliminary safety and performance of the Electrosurgery Applicator (ANET device) during and after bronchoscopic ablation of a target pulmonary nodule/tumor.

NCT ID: NCT03272971 Terminated - Lung Cancer Clinical Trials

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

Start date: December 5, 2017
Phase: N/A
Study type: Interventional

The feasibility of a RF ablation catheter to bronchoscopically ablate lung tumors, will be evaluated in patients already scheduled for surgical resection.

NCT ID: NCT02308865 Terminated - Clinical trials for Lung Cancer Metastatic

Early Palliative Care in Metastatic Lung Cancer in Northern France

IMPAQ
Start date: October 17, 2014
Phase: N/A
Study type: Interventional

Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer